Epidemiology and risk factors for extension of necrotizing otitis externa.

Diabetes Necrotizing otitis externa Osteomyelitis Otalgia Scintigraphy

Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
18 Mar 2024
Historique:
received: 30 11 2023
accepted: 12 02 2024
medline: 19 3 2024
pubmed: 19 3 2024
entrez: 19 3 2024
Statut: aheadofprint

Résumé

Necrotizing otitis externa (OEN) is an aggressive and morbid infection of the external acoustic meatus. What are the risk factors for OEN extension? French monocentric retrospective study (2004-2021), including patients with OEN defined by the association of an inflamed EAM, a positive nuclear imaging, the presence of a bacteriological sample and the failure of a well-followed local and/or general antibiotic treatment. OEN was extensive if it was associated with vascular or neurological deficits, if nuclear imaging fixation and/or bone lysis extended beyond the tympanic bone. Our population (n = 39) was male (74%), type 2 diabetic (72%), aged 75.2 years and pseudomonas aeruginosa was found in 88% of cases. Complications for 43% of patients were extensive fixation on nuclear imaging, for 21% of them the presence of extensive bone lysis, for 13% the appearance of facial palsy, for 5.3% the presence hypoglossal nerve palsy and for 2.5% the presence of thrombophlebitis or other nerves palsies. 59% of our population had extensive OEN. The diagnosis of the extensive OEN was made 22 days later (p = 0.04). The clinical presentation was falsely reassuring due to easier identification of the tympanic membrane (70% vs 46%, p = 0.17) but associated with periauricular oedema (42% vs 0%), bone exposure (16% vs 0%) and a temporomandibular joint pain (41% vs 12%). Delayed treatment of OEN, identification of clinical bone lysis, especially when the tympanic membrane is easily visualized, and the presence of unbalanced diabetes are potential risk factors for extension of OEN.

Identifiants

pubmed: 38499694
doi: 10.1007/s00405-024-08549-5
pii: 10.1007/s00405-024-08549-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Takata J, Hopkins M, Alexander V, Bannister O, Dalton L, Harrison L et al (2023) Systematic review of the diagnosis and management of necrotising otitis externa: highlighting the need for high-quality research. Clin Otolaryngol 48(3):381–394
doi: 10.1111/coa.14041 pubmed: 36759416
Toulmouche, M. Observations on cerebral otorrhoea: further deliberations. Gaz Med Paris. 1838.
Nadol JB (1980) Histopathology of Pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis. Am J Otolaryngol 1(5):359–371
doi: 10.1016/S0196-0709(80)80016-0 pubmed: 7457757
van Kroonenburgh AMJL, van der Meer WL, Bothof RJP, van Tilburg M, van Tongeren J, Postma AA (2018) Advanced imaging techniques in skull base osteomyelitis due to malignant otitis externa. Curr Radiol Rep 6(1):3
doi: 10.1007/s40134-018-0263-y pubmed: 29416952 pmcid: 5778178
Chandler JR (1968) Malignant external otitis. Laryngoscope 78(8):1257–1294
doi: 10.1288/00005537-196808000-00002 pubmed: 4970362
Rubin J, Yu VL (1988) Malignant external otitis: Insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med 85(3):391–8
doi: 10.1016/0002-9343(88)90592-X pubmed: 3046354
Stern Shavit S, Soudry E, Hamzany Y, Nageris B (2016) Malignant external otitis: Factors predicting patient outcomes. Am J Otolaryngol 37(5):425–430
doi: 10.1016/j.amjoto.2016.04.005 pubmed: 27311346
Soudry E, Joshua BZ, Sulkes J, Nageris BI (2007) Characteristics and prognosis of malignant external otitis with facial paralysis. Arch Otolaryngol Head Neck Surg 133(10):1002–1004
doi: 10.1001/archotol.133.10.1002 pubmed: 17938323
Cohen D, Friedman P (1987) The diagnostic criteria of malignant external otitis. J Laryngol Otol 101(3):216–221
doi: 10.1017/S0022215100101562 pubmed: 3106547
Peled C, El-Seid S, Bahat-Dinur A, Tzvi-Ran LR, Kraus M, Kaplan D (2019) Necrotizing Otitis externa—analysis of 83 cases: clinical findings and course of disease. Otol Neurotol 40(1):56–62
doi: 10.1097/MAO.0000000000001986 pubmed: 30239427
Sturm JJ, Stern Shavit S, Lalwani AK (2020) What is the best test for diagnosis and monitoring treatment response in malignant otitis externa? Laryngoscope 130(11):2516–2517
doi: 10.1002/lary.28609 pubmed: 32159853
Lau K, Scotta G, Wu K, Kabuli MAK, Watson G (2020) A review of thirty-nine patients diagnosed with necrotising otitis externa over three years: Is CT imaging for diagnosis sufficient? Clin Otolaryngol 45(3):414–418
doi: 10.1111/coa.13507 pubmed: 31977136
Department of Otorhinolaryngology, Ege University School of Medicine, Izmir, Turkey, Kaya I, Sezgin B, Department of Otorhinolaryngology, Ege University School of Medicine, Izmir, Turkey, Eraslan S, Department of Otorhinolaryngology, Ege University School of Medicine, Izmir, Turkey, et al. Malignant Otitis Externa: A Retrospective Analysis and Treatment Outcomes. Turk Otolarengoloji ArsiviTurkish Arch Otolaryngol. 2018; 56(2): 106‑10.
Strashun AM, Nejatheim M, Goldsmith SJ (1984) Malignant external otitis: early scintigraphic detection. Radiology 150(2):541–545
doi: 10.1148/radiology.150.2.6228955 pubmed: 6228955
Mehrotra P, Elbadawey MR, Zammit-Maempel I (2011) Spectrum of radiological appearances of necrotising external otitis: a pictorial review. J Laryngol Otol 125(11):1109–1115
doi: 10.1017/S0022215111001691 pubmed: 21846417
Mahdyoun P, Pulcini C, Gahide I, Raffaelli C, Savoldelli C, Castillo L et al (2013) Necrotizing otitis externa: a systematic review. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 34(4):620–9
doi: 10.1097/MAO.0b013e3182804aee
Hodgson SH, Sinclair VJ, Arwyn-Jones J, Oh K, Nucken K, Perenyei M et al (2022) Characteristics, management and outcome of a large necrotising otitis externa case series: need for standardised case definition. J Laryngol Otol 136(7):604–610
doi: 10.1017/S002221512100462X pubmed: 35042578 pmcid: 9257435
Lee SK, Lee SA, Seon SW, Jung JH, Lee JD, Choi JY et al (2017) Analysis of prognostic factors in malignant external otitis. Clin Exp Otorhinolaryngol 10(3):228–35
doi: 10.21053/ceo.2016.00612 pubmed: 27671716
Soheilipour S, Meidani M, Derakhshandi H, Etemadifar M (2013) Necrotizing external otitis: a case series. B-ENT 9(1):61–66
pubmed: 23641593
Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR (2007) Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope 117(5):907–10
doi: 10.1097/MLG.0b013e318039b30f pubmed: 17473694
Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V (2007) Necrotizing external otitis: a report of 46 cases. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol 28(6):771–3
doi: 10.1097/MAO.0b013e31805153bd
Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI (2008) Predicting outcome of malignant external otitis. Otol Neurotol 29(3):339–343
doi: 10.1097/MAO.0b013e3181661879 pubmed: 18317396
Pulcini C, Mahdyoun P, Cua E, Gahide I, Castillo L, Guevara N (2012) Antibiotic therapy in necrotising external otitis: case series of 32 patients and review of the literature. Eur J Clin Microbiol Infect Dis 31(12):3287–94
doi: 10.1007/s10096-012-1694-7 pubmed: 22810173

Auteurs

Elise Krawiec (E)

Departments of Oto-Rhino-Laryngology, University Hospital of Reims, Rue du Général Koenig, 51100, Reims, France.

Esteban Brenet (E)

Departments of Oto-Rhino-Laryngology, University Hospital of Reims, Rue du Général Koenig, 51100, Reims, France.

France Truong (F)

Departments of Oto-Rhino-Laryngology, University Hospital of Reims, Rue du Général Koenig, 51100, Reims, France.

Yohan Nguyen (Y)

Department of Internal Medicine, Infectious Diseases and Clinical Immunology, University Hospital of Reims, Reims, France.

Dimitri Papthanassiou (D)

Nuclear Medicine Department, Institut Godinot, Reims, France.

Marc Labrousse (M)

Departments of Oto-Rhino-Laryngology, University Hospital of Reims, Rue du Général Koenig, 51100, Reims, France.

Xavier Dubernard (X)

Departments of Oto-Rhino-Laryngology, University Hospital of Reims, Rue du Général Koenig, 51100, Reims, France. xdubernard@chu-reims.fr.

Classifications MeSH